Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Phase IIa part: - To establish the recommended dose (RD) of L19IL2 when administered in combination with a fixed dose of DTIC in patients with metastatic melanoma, the preliminary tolerability profile of the combination. Phase IIb part: - To evaluate objective response rate (ORR) after 8 cycles (week 24)
Critère d'inclusion
- Histologically or cytologically confirmed unresectable metastatic (stage IV) non-uveal melanoma